Cash & equivalents increased 1096.4%
Cash & equivalents changed +1096.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +1096.4% from the comparable as-filed period.
Gross margin changed -2261 basis points from the comparable as-filed period.
Gross profit changed -34.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed -169.9% from the comparable as-filed period.
Operating income changed -271.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -44799 basis points from the comparable as-filed period.
Research & development changed +33.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +150.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.